Celiac disease genes beyond HLA: what large genetic studies found
Short answer
A 2011 study of Europeans counted 39 known regions outside HLA, and together they explain 13.7% of celiac disease genetic variance1, 2. A 2020 paper says the HLA-DQ gene testing available in clinic does not include non-HLA risk31. Coeliac UK's page for clinicians says no firm conclusions have been made about the importance of the other genes studied, and adds "nor do we routinely test for them"3.
Part of Celiac genetics and family risk, 15 guides

Key points
- Celiac disease almost always occurs with DQ2 or DQ8, but about 30 percent of people carry one of them and only about 3 percent of carriers develop celiac disease, per NIDDK7,6.
- A 2011 study counted 40 known risk loci, HLA included; the 39 outside HLA explained 13.7% of genetic variance there, and HLA about 40% more1,2.
- Most of the new regions in the 2010 study contain immune function genes12, and many variants sit in non-coding regions, which a 2020 review says suggests an effect on gene expression21.
- Coeliac UK's page for clinicians says no firm conclusions have been made about the importance of the other genes studied, and adds "nor do we routinely test for them"3; the 23andMe celiac report FDA reviewed in 2017 reads one HLA variant28.
- For non-celiac wheat sensitivity, a 2020 review says very little is known about the genetics23.
What a genome-wide study is
A genome-wide association study compares how often many genetic variants turn up in people with a condition and in people without it19. Coeliac UK describes one it funded: over 300,000 variants in 778 people with coeliac disease and 1,422 without19.
In the 2011 dense-genotyping study, 29 of 54 fine-mapped signals appeared localized to specific single genes, some of them to gene regulatory elements16.
Two large studies: 2010 and 2011
This section covers two large studies: a 2010 genome-wide association study and a 2011 dense-genotyping study of loci already reported for immune-mediated diseases. The table sets out what each counted.
| 2010 (Dubois and colleagues) | 2011 (Trynka and colleagues) | |
|---|---|---|
| People studied | 4,533 people with celiac disease and 10,750 controls in the first stage9 | 12,041 people with celiac disease and 12,228 controls15 |
| Follow-up | Variants genotyped in a further 4,918 cases and 5,684 controls10 | Dense genotyping of 183 non-HLA loci already reported for immune-mediated diseases15 |
| New regions | 13 new regions reached genome-wide significance11 | 13 new risk loci, bringing the known total to 40 counting HLA1 |
| What it found in them | Most contain immune function genes12 | Multiple independent association signals at over a third of the loci in the study17 |
Separately, Coeliac UK's account of the study it funded names its first finding: the interleukin-2 and interleukin-21 genes, which it describes as important in determining how strong an immune response is made20.
What the non-HLA regions have in common
In the 2010 study, most of the 13 new regions contain immune function genes, and four of the genes it names (ETS1, RUNX3, THEMIS and TNFRSF14) play key roles in thymic T cell selection12.
A 2020 review says the non-HLA variants are mainly single nucleotide polymorphisms in non-coding regions, often within enhancers, suggesting an effect on gene expression rather than on protein function21. The 2010 paper reports that over half the associated variants were correlated with expression changes in nearby genes13.
The same review notes that several other immune-mediated diseases share susceptibility loci with celiac disease22. A region on a celiac list may therefore also turn up for other conditions.
How much of the inherited risk each part accounts for
Three published estimates give a sense of the proportions. They come from different designs, so they are not one number measured three times.
| Study | Design | What it estimated |
|---|---|---|
| Kuja-Halkola and colleagues, 2016 (Gut) | 107,912 Swedish twins; celiac disease identified from biopsy reports25 | Heritability of celiac disease 75% (95% CI 55% to 96%); non-HLA heritability 68% (95% CI 40% to 96%)26 |
| Trynka and colleagues, 2011 | Case-control: 12,041 cases and 12,228 controls15 | In Europeans, the 39 non-HLA loci explain 13.7% of celiac genetic variance; HLA accounts for a further ~40%2 |
| Dubois and colleagues, 2010 | Case-control: 4,533 cases and 10,750 controls in the first stage9 | The HLA variants plus 26 further loci explain about 20% of total celiac variance, which would be 40% of genetic variance if heritability is 0.514 |
The twin study's authors write that HLA seems to have only moderate impact on heritability estimates27. The 2011 authors expect a long tail of effects of weaker significance to explain substantial additional heritability18, and the 2010 authors say a long tail of low effect size common variants, along with rare variants, may contribute to the remaining heritability14.
Do clinical tests cover these variants?
Coeliac UK's guidance for healthcare professionals says that of the many other genes looked at as candidates for the extra risk beyond HLA, no firm conclusions have been made about their importance, adding "nor do we routinely test for them"3. It also says genetic testing in the diagnosis pathway is not routinely recommended4, and that HLA typing is used in specific clinical at-risk scenarios, primarily to exclude the condition5. That is a UK charity's account.
One consumer test that FDA reviewed is narrower still. FDA's 2017 review of the 23andMe celiac report says it is based on a qualitative test for a single nucleotide polymorphism, rs2187668, which detects the HLA-DQ2.5 haplotype28. The review adds that the report does not describe a person's overall risk for developing celiac disease29.
A 2020 pilot of a 42-variant risk score
A 2020 paper built a 42-variant genetic risk score from the European case-control study, using HLA-DQ imputation and published genome-wide association studies, then tested it in a pilot of 128 children with suspected coeliac disease32. Its authors write that scores of this kind can discriminate coeliac disease but had not been validated in clinic30, and that HLA-DQ gene testing, which is available in clinic, does not include non-HLA attributed risk31.
In UK Biobank the score did better than HLA-DQ stratification: an area under the curve of 0.88 against 0.8233. The authors conclude it could facilitate non-invasive diagnosis but needs detailed assessment in the context of other diagnostic tests and against current diagnostic algorithms34.
NIDDK says researchers are studying other genes that may increase the chance of developing celiac disease in people who have DQ2 or DQ88. That is research.
Non-celiac gluten sensitivity: what genetic evidence exists
A 2020 review of genes beyond HLA in gluten-related disorders calls the condition non-celiac wheat sensitivity (NCWS). It says that, in contrast with celiac disease, very little is known about its genetics23.
On HLA, the review reports that DQ2 and DQ8 are present in about 40–50% of NCWS patients, a percentage slightly above the prevalence of these haplotypes in the general population, which it takes to suggest that DQ2/DQ8 has minor relevance, if any, in the development of NCWS24. Compare that with celiac disease, where NIDDK says the disease almost always occurs in people with DQ2 or DQ87.
Against that statement, a list of "gluten sensitivity genes" needs a named study behind it23.
Questions to put to a list of "celiac genes"
A list that calls itself "celiac genes" or "gluten sensitivity genes" can be held against what the studies above report:
- Does it include HLA-DQ2 or DQ8? NIDDK says celiac disease almost always occurs in people with one of them7, but about 30 percent of people have DQ2 or DQ8 and only about 3 percent of those develop celiac disease6.
- Does it cite a genome-wide study with cases and controls, such as the 2010 and 2011 papers9,15? If it names none, there is no study behind it for you to check.
- Does it say how much each variant changes risk? In the 2011 study, all 39 non-HLA loci together explain 13.7% of genetic variance2; a list implying one gene decides the matter does not describe that.
- Does it claim a clinical use? Coeliac UK's page says no firm conclusions have been made about the other genes and adds "nor do we routinely test for them"3, and the 2020 risk score was a pilot whose authors say it needs detailed assessment34.
- Does it treat gluten sensitivity as inherited? For NCWS, a review says very little is known about the genetics23.
Questions people ask
Is there one celiac gene?
Not by itself. NIDDK says celiac disease almost always occurs in people with DQ2 or DQ87, but only about 3 percent of people with DQ2 or DQ8 develop it6, and the 2011 study counted 39 further regions outside HLA1.
How many genes are linked to celiac disease?
The 2011 study counted 40 known risk loci including HLA1. A locus is a region: in that study 29 of 54 fine-mapped signals appeared localized to specific single genes16.
Can a test of these genes diagnose celiac disease?
Coeliac UK says genetic testing in the diagnosis pathway is not routinely recommended4, and its page on the other genes adds "nor do we routinely test for them"3. A 2020 paper says the HLA-DQ testing available in clinic does not include non-HLA risk31. A 2020 pilot of a 42-variant score said it needs detailed assessment against current diagnostic algorithms34.
More in Celiac genetics and family risk
Can eating too much gluten cause celiac disease? What genes, trials and cohort studies showWhat NIDDK, two infant-feeding trials and the TEDDY cohort studies report on genes, gluten amount and celiac disease risk, and what is still unknown.
Is celiac disease hereditary? What runs in families and what does notWhat NIDDK and pooled studies report on inherited risk for celiac disease: the DQ2 and DQ8 genes, twin data, and how rates differ among relatives.
Celiac genetic testing: what HLA-DQ2 and DQ8 results can and cannot tell youWhat HLA-DQ2 and DQ8 typing checks for, how NIDDK, ACG, ESPGHAN and WGO read a negative or positive result, and where the guidelines place the test.
Celiac genetic test results in the US: who can see them, and what the law coversWhat US law covers when a genetic test result exists, such as a celiac HLA result: health insurance, jobs, the gaps, and a test company's policy.
23andMe versus a clinical HLA test for celiac disease: what each reads and what a negative meansWhich gene variants the FDA-authorized 23andMe celiac report and clinical HLA typing read, and how labs and charities describe a negative or positive.
A positive celiac gene test in your child: what it means and what happens nextWhat a positive HLA (DQ2 or DQ8) result in a child means, why sources say gluten stays in the diet until testing, and what clinicians check next.
Related guides
HLA-DQ2 and HLA-DQ8 explained: the allele names on a celiac gene reportWhat DQA1, DQB1, DQ2.5, DQ2.2 and DQ8 mean on a celiac gene report, how often each appears in celiac disease, and how common they are overall.
Celiac disease vs gluten intolerance: three conditions, three diagnosesHow celiac disease, non-celiac gluten sensitivity and wheat allergy differ in mechanism, diagnosis and diet, with a source behind every point.
Sources
- [1, 2, 15, 16, 17, 18] Nature Genetics (PubMed Central), Trynka et al. 2011: Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease, checked Nov 17, 2026.
- [3, 4, 5] Coeliac UK, Genetics and coeliac disease testing (healthcare professionals), checked Nov 17, 2026.
- [6, 7, 8] US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Symptoms and Causes of Celiac Disease, checked Nov 17, 2026.
- [9, 10, 11, 12, 13, 14] Nature Genetics (PubMed Central), Dubois et al. 2010: Multiple common variants for celiac disease influencing immune gene expression, checked Nov 17, 2026.
- [19, 20] Coeliac UK, The genetic basis of coeliac disease (research project), checked Nov 17, 2026.
- [21, 22, 23, 24] Frontiers in Nutrition (PubMed Central), Sallese et al. 2020: Beyond the HLA Genes in Gluten-Related Disorders, checked Nov 17, 2026.
- [25, 26, 27] Gut (PubMed), Kuja-Halkola et al. 2016: Heritability of non-HLA genetics in coeliac disease, a population-based study in 107 000 twins, checked Nov 17, 2026.
- [28, 29] US Food and Drug Administration, De Novo review DEN160026: 23andMe Personal Genome Service Genetic Health Risk tests, checked Nov 17, 2026.
- [30, 31, 32, 33, 34] Alimentary Pharmacology and Therapeutics (PubMed), Sharp et al. 2020: A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease, a pilot study in clinical care, checked Nov 17, 2026.